On the Origins of the Androgen Receptor Low Molecular Weight Species

ISSN： 1868-8497

Source： Hormones and Cancer, Vol.4, Iss.5, 2013-10, pp. : 259-269

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

A novel low molecular weight VEGF receptor-binding antagonist, VGA1102, inhibits the function of VEGF and in vivo tumor growth

By Ueda Yasuji Yamagishi Takehiro Samata Kazunori Ikeya Hisao Hirayama Noriko Okazaki Tadayasu Nishihara Sumi Arai Koshi Yamaguchi Sachiko Shibuya Masabumi Nakaike Shiro Tanaka Makoto

Cancer Chemotherapy and Pharmacology, Vol. 54, Iss. 1, 2004-07 ,pp. : 16-24

Springer Publishing Company

Access to resources Recommend Favorite

Low Molecular Weight Heparins as Antineoplastic Agents

Recent Patents on Anti-Cancer Drug Discovery, Vol. 3, Iss. 3, 2008-11 ,pp. : 159-161

Bentham Science Publishers

Access to resources Recommend Favorite

The Androgen Receptor and Mechanisms for Androgen Independence in Prostate Cancer

By Javidan Javid Deitch Arline Shi Xu-Bao de Vere White Ralph

Cancer Investigation, Vol. 23, Iss. 6, 2005-09 ,pp. : 520-528

Informa Healthcare

Access to resources Recommend Favorite

Low-Molecular-Weight Compound Development - Technology Pertinent to Men's Health

The Genesis Report - Rx, Vol. 9, Iss. 2, 2000-02 ,pp. : 23-32

Adis International

Access to resources Recommend Favorite

Androgen Receptor Signaling in Bladder Cancer

By Li Peng Chen Jinbo Miyamoto Hiroshi

Cancers, Vol. 9, Iss. 2, 2017-02 ,pp. : 20-20

MDPI

Access to resources Recommend Favorite